Singleron Biotechnologies

About:

Singleron Biotechnologies is an innovative molecular diagnostic company.

Website: https://singleron.bio/

Top Investors: Tencent, ARCH Venture Partners, Frees Fund, Lilly Asia Ventures, CDH Investments

Description:

Singleron Biotechnologies is a developer and provider of clinical diagnosis, health management and drug development products and services. The company is dedicated to applying single cell analysis techniques and has obtained a world wide exclusive IP license from Yale University for its uniquely designed microfluidic single cell processing device, and has developed the innovative SCOPE single-cell pre-sequencing preparation system based on this microfluidic device.

Total Funding Amount:

$145M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nanjing, Jiangsu, China

Founded Date:

2018-01-01

Contact Email:

singleron(AT)singleronbio.com

Founders:

Jing Zhou, Nan Fang

Number of Employees:

501-1000

Last Funding Date:

2021-11-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai